A systematic review 1 including 28 RCTs (46,254 men with 4241 recorded events), 10 cohort studies (494,804 men and 54,832 women) was abstracted in DARE.
For cohort studies, a decrease in serum cholesterol concentration of 0.6 mmol/L (10%) was associated with a decrease in risk of ischaemic heart disease by 54% at age 40, 39% at age 50, 27% at age 60, 20% at age 70, and 19% at age 80.
According to the RCTs, the reduction in ischaemic heart disease increased with increasing duration of the reduction in cholesterol concentration: 2 years by 7%, 2.1 - 5 years by 22%, 5.1 - 12 years by 25%, all per 0.6 mmol/l reduction in concentration.
Comment: The review does not address effects on all cause morbidity and mortality.
Primary/Secondary Keywords